Private equity firm Quadria Capital has concluded a Rs 475.31 crore investment in biopharmaceutical active ingredient manufacturer Concord ...

Ahmedabad-based Concord Biotech will invest $20 million in setting up a fermentation facility abroad to save on power and fuel costs.

The ongoing labour strife in Bangladesh over minimum wages may rob the country of its cost-advantage and prove to be a boon for the Indian ...

World’s second-largest generic drug maker Mylan, which held a majority stake in Ahmedabad-based Concord Biotech through its subsidiary Matr...

Indian apparel exporters are battling not only recession blues, but also their more competitive rivals in Bangladesh and Vietnam. The indus...

The quota regime is over, leaving the textile sector with many opportunities to enhance its overall competitiveness.

"I always wanted to become an entrepreneur. And I knew biotech would be the next big thing. I was apprehensive. But I told myself, let me d...

Big pharma companies such as Zydus Healthcare plans to focus on biotech in a big way.

Concord Biotech, a small Ahmedabad-based biotechnology firm, on Tuesday shipped its first consignment to its new $1.2bn US-based parent, My...